CorMedix (CRMD) Other Non-Current Liabilities (2013 - 2021)
CorMedix's (CRMD) quarterly Other Non-Current Liabilities came in at $163403.0 in Q4 2021, down 91.31% quarter-over-quarter from $1.9 million in Q2 2017.
CorMedix (CRMD) Other Non-Current Liabilities (2013 - 2021) Analysis & Trends
CorMedix has disclosed Other Non-Current Liabilities across 3 years of filings, most recently posting $163403.0 for Q4 2021.
- Other Non-Current Liabilities for Q4 2021 came in at $163403.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $163403.0 (changed N/A YoY), and the FY2021 annual result was $163403.0, changed N/A from the prior year.
- Other Non-Current Liabilities came in at $163403.0 for Q4 2021 at CorMedix, down from $1.9 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.9 million in Q2 2017 to a low of $163403.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 163,403.00 |
| Jun 30, 2017 | 1.88 Mn |
| Dec 31, 2013 | 5.31 Mn |